These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7098615)

  • 21. Rise in plasma alkaline phosphatase at the menopause.
    Crilly RG; Jones MM; Horsman A; Nordin BE
    Clin Sci (Lond); 1980 Apr; 58(4):341-2. PubMed ID: 7379460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoporosis and osteomalacia.
    Nordin BE; Heyburn PJ; Peacock M; Horsman A; Aaron J; Marshall D; Crilly RG
    Clin Endocrinol Metab; 1980 Mar; 9(1):177-205. PubMed ID: 6998609
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of estrogens on serum gonadotropins, prolactin and testosterone in postmenopausal women].
    Tiron V; Eşanu C; Klepsch I
    Rev Med Chir Soc Med Nat Iasi; 1983; 87(3):455-7. PubMed ID: 6676862
    [No Abstract]   [Full Text] [Related]  

  • 24. Parathyroid hormone secretion in women in late menopause submitted to EDTA-induced hypocalcemia.
    Pereira LC; Pereira FA; Sá MF; Foss MC; de Paula FJ
    Maturitas; 2008 Jan; 59(1):91-4. PubMed ID: 18037250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relationship between serum 1,25-dihydroxyvitamin D and bone loss in postmenopausal women].
    Zhu G; Wang H; Xu P
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(23):1443-6. PubMed ID: 11930618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endocrine transition around menopause--a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women.
    Overlie I; Moen MH; Morkrid L; Skjaeraasen JS; Holte A
    Acta Obstet Gynecol Scand; 1999 Aug; 78(7):642-7. PubMed ID: 10422913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of melatonin in perimenopausal and menopausal women: our personal experience.
    Bellipanni G; DI Marzo F; Blasi F; Di Marzo A
    Ann N Y Acad Sci; 2005 Dec; 1057():393-402. PubMed ID: 16399909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Endocrinological examination in infertile female (author's transl)].
    Hirakawa S
    Rinsho Byori; 1979 Oct; 27(10):893-904. PubMed ID: 533910
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum prolidase activity in postmenopausal osteoporosis.
    Namiduru ES; Binnur Erbagci A; Celik A; Yilmaz M; Tarakçioglu M
    Minerva Med; 2007 Dec; 98(6):647-51. PubMed ID: 18299678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 1980 May; 22(11):45-6. PubMed ID: 7374621
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hormone replacement therapy for menopausal women].
    Nozaki M
    Fukuoka Igaku Zasshi; 2000 Mar; 91(3):74-9. PubMed ID: 10917758
    [No Abstract]   [Full Text] [Related]  

  • 32. Decreased bone density in hyperprolactinemic women.
    Klibanski A; Neer RM; Beitins IZ; Ridgway EC; Zervas NT; McArthur JW
    N Engl J Med; 1980 Dec; 303(26):1511-4. PubMed ID: 7432421
    [No Abstract]   [Full Text] [Related]  

  • 33. [Calcium regulating hormones in endocrine and bone diseases (author's transl)].
    Okano K; Nakai R
    Horumon To Rinsho; 1981 Jul; 29(7):837-44. PubMed ID: 7307301
    [No Abstract]   [Full Text] [Related]  

  • 34. Estrogen therapy during menopause.
    Horwitz DL
    Compr Ther; 1980 Mar; 6(3):3-4. PubMed ID: 7363581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Routine determination of urinary hydroxyproline (author's transl)].
    Haury H
    Z Klin Chem Klin Biochem; 1972 Jan; 10(1):25-8. PubMed ID: 4680998
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of estrogen pre-treatment on plasma prolactin response to low-dose naloxone in post-menopausal women.
    Monteleone P; Maj M; Steardo L
    Acta Neurol (Napoli); 1984 Dec; 6(6):418-23. PubMed ID: 6524466
    [No Abstract]   [Full Text] [Related]  

  • 37. Spermatogenesis after parathyroidectomy in patients with symptomatic secondary hyperparathyroidism.
    Chou FF; Lee CH; Lee CT; Huang FJ; Hsu KL
    J Am Coll Surg; 2003 Jun; 196(6):854-8. PubMed ID: 12788420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prolactin: estimation and interest in clinical biology (author's transl)].
    Lemaitre BJ
    Ann Biol Clin (Paris); 1980; 38(3):151-6. PubMed ID: 7192521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of cortical osteoporosis in mild and severe primary hyperparathyroidism and its relationship with bone markers and vitamin D status.
    Bandeira F; Griz LH; Bandeira C; Pinho J; Lucena CS; Alencar C; Thé AC; Diniz ET
    J Clin Densitom; 2009; 12(2):195-9. PubMed ID: 19138544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can osteoporosis be prevented?
    Skillman TG
    Geriatrics; 1980 Feb; 35(2):95-102. PubMed ID: 7356592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.